Table 1 Reported cases of gastrointestinal stromal tumor in perforated Meckel's diverticulum (n = 18)
Report | Year | Gender | Age | Operative findings | Treatment | Follow up | Tumor size (cm) | Mitotic figure (/50HPFs) | Risk classification* |
|---|---|---|---|---|---|---|---|---|---|
Fruhauf [9] | 2002 | M | 61 | Peritonitis | NR | NR | NR | High | – |
Szentpáli [10] | 2004 | M | 70 | Peritonitis | SBR | Alive 3Y | 1.5 | Low | Very low |
Hager [11] | 2005 | M | 75 | Peritonitis | NR | NR | NR | NR | – |
Woolf [12] | 2009 | M | 59 | Peritonitis, haemorrhage | SBR | Alive | 4.5 | < 5 | Low |
Caricato [13] | 2010 | M | 65 | Peritonitis | SBR | Alive 2Y | 4.5 × 3.7 × 3.5 | 1 | Low |
Chou [14] | 2011 | F | 76 | Peritonitis | SBR | NR | 3.2 | 6 | Intermitted |
Dogrul [15] | 2011 | F | 86 | Peritonitis | SBR | Dead 2 months | 8 | High | High |
Sozen [16] | 2012 | F | 62 | Peritonitis | SBR | NR | 2.5 | 6 | Intermitted |
Mitula [17] | 2012 | F | 63 | Peritonitis | SBR | Alive 6 months | 14 | High | High |
Goyal [18] | 2013 | M | 23 | Abscess | SBR, imatinib | Alive 1Y | 4.8 × 4.2 × 4.2 | < 5 | Low |
Fernandez [19] | 2013 | NR | NR | Peritonitis | SBR, imatinib | NR | NR | NR | – |
Nayak [20] | 2015 | M | 50 | Peritonitis | SBR | NR | NR | NR | – |
Kiliç [21] | 2015 | F | 37 | Peritonitis | SBR, imatinib | NR | 4.5 × 2.5 × 2.5 | 10 | Intermitted |
Ikemura [22] | 2015 | M | 82 | Peritonitis | SBR, imatinib | Alive 22 months | 2.5 | 1 | Low |
Hosamani [23] | 2016 | M | 40 | Peritonitis | SBR, imatinib | Alive 5Y | 3 × 1 × 1 | 2 | Low |
Omerza [24] | 2016 | M | 55 | Peritonitis | SBR, imatinib | NR | 3.5 × 8 | < 5 | Intermitted |
Miyata [25] | 2016 | M | 62 | Peritonitis | SBR, imatinib | NR | 4 | 0 | Low |
Our case | 2018 | F | 56 | Peritonitis | SBR | Alive 1Y | 1 × 1 | < 5 | Very low |